PE-backed medical device companies Argentum Medical and BioDerm merge

Mountaingate Capital, which invested in the newly combined entity, was an existing investor in BioDerm.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this